Chinese General Practice ›› 2023, Vol. 26 ›› Issue (33): 4187-4193.DOI: 10.12114/j.issn.1007-9572.2023.0115
Special Issue: 中医最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-02-01
Revised:
2023-05-28
Published:
2023-11-20
Online:
2023-06-13
Contact:
FENG Xiaodong
通讯作者:
冯晓东
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0115
评分 | 表现 |
---|---|
0分 | 无缺损症状;无神经损伤 |
1分 | 提尾时对侧前肢内收屈曲;轻度神经损伤 |
2分 | 向对侧追尾式旋转;中度神经损伤 |
3分 | 行走费力且向对侧倾倒;重度神经损伤 |
4分 | 不能自发活动伴意识丧失;极重度神经损伤 |
Table 1 Zea-Longa scoring criteria
评分 | 表现 |
---|---|
0分 | 无缺损症状;无神经损伤 |
1分 | 提尾时对侧前肢内收屈曲;轻度神经损伤 |
2分 | 向对侧追尾式旋转;中度神经损伤 |
3分 | 行走费力且向对侧倾倒;重度神经损伤 |
4分 | 不能自发活动伴意识丧失;极重度神经损伤 |
基因 | 引物序列(5'→3') |
---|---|
BDNF | F:GACTCCCCGGCTTGGAGAAG R:CTGAGGGAACCCGGTCTCAT |
TrkB | F:GGATTCTGCCTGCTGGTGAT R:ACCCATCCAGGGGGATCTTAT |
PI3K | F:ATCGACCTACACTTGGGGGA R:CAATATCTTCTGGCCGGGCT |
Akt | F:AGGAGGTCATCGTTGCCAAG R:GGTCGTGGGTCTGGAATGAG |
GAPDH | F:ACAGCAACAGGGTGGTGGAC R:TTTGAGGGTGCAGCGAACTT |
Table 2 RT-PCR primer sequence
基因 | 引物序列(5'→3') |
---|---|
BDNF | F:GACTCCCCGGCTTGGAGAAG R:CTGAGGGAACCCGGTCTCAT |
TrkB | F:GGATTCTGCCTGCTGGTGAT R:ACCCATCCAGGGGGATCTTAT |
PI3K | F:ATCGACCTACACTTGGGGGA R:CAATATCTTCTGGCCGGGCT |
Akt | F:AGGAGGTCATCGTTGCCAAG R:GGTCGTGGGTCTGGAATGAG |
GAPDH | F:ACAGCAACAGGGTGGTGGAC R:TTTGAGGGTGCAGCGAACTT |
组别 | 只数 | 术后2 h | 治疗第7天 | 治疗第14天 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | ||
空白组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
假手术组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
模型组abcdef | 12 | 0 | 1(8.3) | 2(16.7) | 9(75.0) | 0 | 0 | 2(16.7) | 3(25.0) | 7(58.3) | 0 | 0 | 3(25.0) | 7(58.3) | 2(16.7) | 0 |
电针组abgh | 12 | 0 | 1(8.3) | 3(25.0) | 8(66.7) | 0 | 0 | 6(50.0) | 4(33.3) | 2(16.7) | 0 | 4(33.3) | 7(58.3) | 1(8.3) | 0 | 0 |
H值 | 42.53 | 42.17 | 37.81 | |||||||||||||
P值 | <0.05 | <0.05 | <0.05 |
Table 3 Comparison of Zea-Longa scores among 4 groups of rats
组别 | 只数 | 术后2 h | 治疗第7天 | 治疗第14天 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | ||
空白组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
假手术组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
模型组abcdef | 12 | 0 | 1(8.3) | 2(16.7) | 9(75.0) | 0 | 0 | 2(16.7) | 3(25.0) | 7(58.3) | 0 | 0 | 3(25.0) | 7(58.3) | 2(16.7) | 0 |
电针组abgh | 12 | 0 | 1(8.3) | 3(25.0) | 8(66.7) | 0 | 0 | 6(50.0) | 4(33.3) | 2(16.7) | 0 | 4(33.3) | 7(58.3) | 1(8.3) | 0 | 0 |
H值 | 42.53 | 42.17 | 37.81 | |||||||||||||
P值 | <0.05 | <0.05 | <0.05 |
组别 | 只数 | 第9天 | 第10天 | 第11天 | 第12天 | 第13天 |
---|---|---|---|---|---|---|
空白组 | 12 | 38.6±5.0 | 31.1±5.9 | 25.8±4.5 | 13.9±3.7 | 8.4±3.3 |
假手术组 | 12 | 37.7±7.2 | 31.4±6.2 | 25.1±5.6 | 14.0±4.2 | 8.2±3.4 |
模型组 | 12 | 51.9±6.3ab | 42.4±6.0ab | 34.5±5.0ab | 27.5±5.1ab | 20.7±5.9ab |
电针组 | 12 | 46.5±6.2c | 37.6±5.1c | 29.5±4.9c | 20.4±3.3c | 12.4±4.2c |
F值 | F交互=1.191,F组间=52.513,F时间=277.985 | |||||
P值 | P交互=0.30,P组间<0.05,P时间<0.05 |
Table 4 Comparison of incubation period among 4 groups of rats
组别 | 只数 | 第9天 | 第10天 | 第11天 | 第12天 | 第13天 |
---|---|---|---|---|---|---|
空白组 | 12 | 38.6±5.0 | 31.1±5.9 | 25.8±4.5 | 13.9±3.7 | 8.4±3.3 |
假手术组 | 12 | 37.7±7.2 | 31.4±6.2 | 25.1±5.6 | 14.0±4.2 | 8.2±3.4 |
模型组 | 12 | 51.9±6.3ab | 42.4±6.0ab | 34.5±5.0ab | 27.5±5.1ab | 20.7±5.9ab |
电针组 | 12 | 46.5±6.2c | 37.6±5.1c | 29.5±4.9c | 20.4±3.3c | 12.4±4.2c |
F值 | F交互=1.191,F组间=52.513,F时间=277.985 | |||||
P值 | P交互=0.30,P组间<0.05,P时间<0.05 |
组别 | 只数 | 穿越平台次数 |
---|---|---|
空白组 | 12 | 7.99±2.71 |
假手术组 | 12 | 7.64±3.20 |
模型组 | 12 | 2.19±1.52ab |
电针组 | 12 | 4.87±1.65c |
F值 | 15.57 | |
P值 | <0.05 |
Table 5 Comparison of times of crossing the effective region of the platform among 4 groups of rats
组别 | 只数 | 穿越平台次数 |
---|---|---|
空白组 | 12 | 7.99±2.71 |
假手术组 | 12 | 7.64±3.20 |
模型组 | 12 | 2.19±1.52ab |
电针组 | 12 | 4.87±1.65c |
F值 | 15.57 | |
P值 | <0.05 |
组别 | 例数 | BDNF | TrkB | PI3K | Akt |
---|---|---|---|---|---|
空白组 | 3 | 1.00±0.09 | 1.00±0.02 | 1.00±0.12 | 1.00±0.20 |
假手术组 | 3 | 0.99±0.04 | 1.00±0.02 | 1.03±0.10 | 1.00±0.10 |
模型组 | 3 | 0.23±0.03ab | 0.48±0.10ab | 0.55±0.04ab | 0.53±0.05ab |
电针组 | 3 | 0.76±0.08c | 0.75±0.07c | 0.88±0.16c | 0.90±0.09c |
F值 | 91.95 | 44.87 | 11.45 | 10.35 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
Table 6 Comparison of mRNA levels of BDNF,TrkB,PI3K and Akt in hippocampal tissues of four groups
组别 | 例数 | BDNF | TrkB | PI3K | Akt |
---|---|---|---|---|---|
空白组 | 3 | 1.00±0.09 | 1.00±0.02 | 1.00±0.12 | 1.00±0.20 |
假手术组 | 3 | 0.99±0.04 | 1.00±0.02 | 1.03±0.10 | 1.00±0.10 |
模型组 | 3 | 0.23±0.03ab | 0.48±0.10ab | 0.55±0.04ab | 0.53±0.05ab |
电针组 | 3 | 0.76±0.08c | 0.75±0.07c | 0.88±0.16c | 0.90±0.09c |
F值 | 91.95 | 44.87 | 11.45 | 10.35 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
组别 | 只数 | BDNF | TrkB | p-PI3K/PI3K | p-Akt/Akt |
---|---|---|---|---|---|
空白组 | 3 | 0.32±0.07 | 0.95±0.04 | 0.58±0.01 | 0.33±0.03 |
假手术组 | 3 | 0.32±0.07 | 0.91±0.06 | 0.59±0.04 | 0.35±0.03 |
模型组 | 3 | 0.08±0.03ab | 0.43±0.02ab | 0.31±0.10ab | 0.17±0.02ab |
电针组 | 3 | 0.23±0.07c | 0.65±0.06c | 0.54±0.09c | 0.32±0.09c |
F值 | 10.58 | 45.22 | 10.66 | 7.62 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
Table 7 Comparison of protein relative expression levels of BDNF,TrkB,p-PI3K/PI3K and p-Akt/Akt in hippocampal tissues of four groups
组别 | 只数 | BDNF | TrkB | p-PI3K/PI3K | p-Akt/Akt |
---|---|---|---|---|---|
空白组 | 3 | 0.32±0.07 | 0.95±0.04 | 0.58±0.01 | 0.33±0.03 |
假手术组 | 3 | 0.32±0.07 | 0.91±0.06 | 0.59±0.04 | 0.35±0.03 |
模型组 | 3 | 0.08±0.03ab | 0.43±0.02ab | 0.31±0.10ab | 0.17±0.02ab |
电针组 | 3 | 0.23±0.07c | 0.65±0.06c | 0.54±0.09c | 0.32±0.09c |
F值 | 10.58 | 45.22 | 10.66 | 7.62 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
[1] |
GBD Causes of Death Collaborators. Global,regional,and national age-sex specific mortality for 264 causes of death,1980-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet,2017,390(10100):1151-1210. DOI:10.1016/S0140-6736(17)32152-9.
|
[2] |
|
[3] |
中国卒中学会,卒中后认知障碍管理专家委员会. 卒中后认知障碍管理专家共识[J]. 中国卒中杂志,2017,12(6):519-531. DOI:10.3969/j.issn.1673-5765.2017.06.011.
|
[4] |
高静,白艳杰,冯晓东. 《欧洲卒中组织与欧洲神经病学学会卒中后认知障碍的联合指南》解读[J]. 华西医学,2022,37(5):641-645. DOI:10.7507/1002-0179.202204020.
|
[5] |
苏凯奇,高静,李洁莹,等. 基于古今医案云平台分析针刺治疗中风后认知障碍选穴规律[J]. 中国针灸,2022,42(1):99-103. DOI:10.13703/j.0255-2930.20201123-k0001.
|
[6] |
刘娇,冯晓东. 电针百会、神庭穴配合康复训练治疗脑卒中后认知障碍临床研究[J]. 中医学报,2013,28(4):608-610.
|
[7] |
薛洋,孙伟娟,刘飞来,等. 电针神庭、百会联合功能康复训练治疗脑卒中后认知障碍42例[J]. 中医研究,2018,31(1):57-60. DOI:10.3969/j.issn.1001-6910.2018.01.25.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
黎帅,谭洁,张泓,等. 穴位埋线对慢性缺血性认知障碍模型大鼠空间学习记忆能力及海马兴奋性氨基酸毒性相关蛋白的影响[J]. 针刺研究,2018,43(6):347-352. DOI:10.13702/j.1000-0607.170385.
|
[14] |
李忠仁. 实验针灸学[M]. 2版. 北京:中国中医药出版社,2007.
|
[15] |
詹杰,潘锐焕,郭友华,等. 针刺百会、神庭联合基础治疗和常规康复训练治疗脑卒中后认知障碍:随机对照研究[J]. 中国针灸,2016,36(8):803-806. DOI:10.13703/j.0255-2930.2016.08.007.html.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
高静,赖名殷,梅氏清心,等. 电针对抑郁大鼠前额叶脑源性神经营养因子/哺乳动物雷帕霉素复合物1通路及突触可塑性的影响[J]. 针刺研究,2022,47(1):15-20,32. DOI:10.13702/j.1000-0607.201293.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[1] | LIAO Kexin, XIAO Yisheng. Effects of the Compatibility Extract of Huangjing Pill on the Hippocampal DG Region Stem Cells in Rats with Learning and Memory Impairments [J]. Chinese General Practice, 2025, 28(24): 3019-3025. |
[2] | YANG Ji, ZHANG Yao, ZHAO Yingqiang, ZHANG Qiuyue. Evaluation of the Effectiveness of TCM Three-level Prevention and Control Model in the Management of Patients with Coronary Heart Disease and Stroke: a Single-center, Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2750-2761. |
[3] | TAN Yi, ZHU Lihong, YIN Zengwei, HOU Shunan, YU Houming. A Real-world Study of MRI-guided Intravenous Thrombolytic Therapy in Acute Ischemic Stroke [J]. Chinese General Practice, 2025, 28(20): 2508-2515. |
[4] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[5] | TAN Wenbin, LI Jia, LIU Mingyu, LU Yongxin, CHENG Yaxin. Research Progress on the Influence of Nervous System Diseases and Related Therapeutic Drugs on Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2092-2100. |
[6] | LI Mei, JIANG Dongsheng, ZHAO Jingjing, CAO Yajing, ZHANG Fan, TANG Lijuan, LIU Xiaoli. Correlation Analysis of Homocysteine and Stroke in People over 40 Years Old [J]. Chinese General Practice, 2025, 28(14): 1723-1729. |
[7] | ZHAO Zhixin, MEI Yongxia, WANG Xiaoxuan, JIANG Hu, WANG Wenna, ZHANG Zhenxiang. Cognition and Experience of Social Participation in Stroke Survivors: a Meta-synthesis Based on Qualitative Studies [J]. Chinese General Practice, 2025, 28(10): 1273-1280. |
[8] | LIU Zuting, XU Minghuan, YANG Xuezhi, MO Jiali, LIU Xingyu, DU Huijie, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between the Systemic Inflammatory Response Index and Risk of Ischemic Stroke Recurrence [J]. Chinese General Practice, 2025, 28(05): 541-547. |
[9] | DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560. |
[10] | ZHANG Pingshu, XUE Jing, XING Aijun, WANG Lianhui, MA Qian, FU Yongshan, YUAN Xiaodong. Study on Sleep Status and Prognostic Factors in Patients with Acute Posterior Circulation Ischemic Stroke [J]. Chinese General Practice, 2025, 28(05): 548-553. |
[11] | ZHOU Chenxi, LIN Beilei, TANG Shangfeng, ZHANG Zhenxiang, WANG Xiaoxuan, JIANG Hu, ZHANG Dudu, LIU Bowen, LI Xin. Construction of Conceptual Framework of Proactive Health Behavior in Stroke Patients [J]. Chinese General Practice, 2025, 28(05): 534-540. |
[12] | NI Xiaojia, LIN Hao, LUO Xufei, KUANG Zhuoran, LIU Yunlan, GUO Jianwen, CHEN Yaolong, CAI Yefeng, Working Group of Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicine (2023 Edition) [J]. Chinese General Practice, 2025, 28(05): 521-533. |
[13] | YUAN Dan, WANG Ying, WANG Yingpeng, XU Li, XUE Jia, CHENG Jingjing, WANG Haipeng. Effect of the Remote Ischemic Postconditioning on the Prognosis of Patients with Acute Ischemic Stroke beyond Time Window: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(02): 169-174. |
[14] | REN Xiaoqiao, WANG Pan, WU Hao, JI Yong, SHI Zhihong. Correlation of Serum Uric Acid to Serum Creatinine Ratio with the Recurrence of Cerebrovascular Events and Mortality in Patients with Acute Cerebrovascular Disease: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(02): 175-182. |
[15] | LIN Jiali, ZHANG Shuyang, LIN Jiaying, ZHOU Yuxin, ZHAO Yuehua, CHEN Yun, JIA Jie. Correlation between Upper Limb Motor Function and Attention after Stroke: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(02): 208-213. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||